Medical/Pharmaceuticals

Sanyou Bio Wins the "2025 Best Customer Satisfaction CRO Award"

SHANGHAI, Aug. 5, 2025 /PRNewswire/ -- The highly anticipated 7th China Bio Innovation Expo was recently held in grand fashion in Suzhou. At the awards ceremony onAugust 1, Sanyou Bio was honored with the "2025 Best Customer Satisfaction CRO Award" in recognition of its deep expertise and outstan...

2025-08-05 22:00 1727

Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Advancing the Next Stage of Diagnostics

* Dr. Jong-Yoon Chun, Chairman and CEO of Seegene, highlights progress toward fully automated and data-driven molecular testing * Introduction of CURECA™, the first fully unattended PCR automation system, and STAgora™, a real-time global data analytics platform * Technologies designed to sca...

2025-08-05 21:07 2310

FigureLabs: World's First AI scientific illustration tool for Effortless Publication Figures

OXFORD, United Kingdom, Aug. 5, 2025 /PRNewswire/ -- FigureLabs, the world's first fully AI-driven scientific illustration tool, has officially launched, marking a significant advancement for researchers worldwide. Designed to streamline the creation of publication-quali...

2025-08-05 21:00 1509

Neopharma Technologies Appoints Exchange Listing to Manage U.S. IPO

NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Neopharma Technologies Ltd (NTL), a leading MedTech company specializing in digital drug and impairment testing for workplace and public safety, has appointed Exchange Listing, LLC to manage its upcoming U.S. initial public offering (IPO), with plans to list...

2025-08-05 21:00 1465

BON Announces Reciept of Nasdaq Compliance Letter

XI'AN, China, Aug. 5, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading provider of bio-ingredient solutions for the natural health and personal care industries, today announced reciept of compliance notification from the Nasdaq Stock Market LLC. As ...

2025-08-05 21:00 3148

Court Sides with Cardiovalve in Edwards patent spat

HANGZHOU, China, Aug. 5, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. ("Venus Medtech", Stock Code: 02500.HK) recently announced a decisive legal victory for its wholly-owned subsidiary Cardiovalve Ltd. ("Cardiovalve") against Edwards Lifesciences Corporation and Edwards Lifesciences LLC. ...

2025-08-05 20:00 1707

iNtRON Bio, Demonstrated Toxin-Neutralizing Effect of IMPA™ Phage Engineering Technology in Colorectal Cancer Model and Completed the US Patent Application

•  Successful validation of payloaded anti-colibactin toxin phage using IMPA™ technology  •  Demonstrated 'Dual-target Therapeutic Strategy' by bacterial eradication and toxin neutralization  •  Filed the US patent application for the candidate substance and preclinical studies including PoC unde...

2025-08-05 20:00 1563

Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Small Molecule Oral GLP-1R Agonist, ASC30, in Participants with Obesity or Overweight

-          13-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of two oral formulations of ASC30, a once-daily tablet, in 125 participants with obesity or overweight. -         All 125 participants enrolled in just over one month; topline data expected in the fourth ...

2025-08-05 18:50 1539

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with AstraZeneca (LSE/STO/Nasdaq: AZN). This new, multi-year collab...

2025-08-05 18:40 1400

Fapon Biopharma Announces the enrollment of the First Patient in the Phase I Clinical Trial of FP008, A First-in-Class Immunotherapy for Solid Tumors

DONGGUAN, China, Aug 5, 2025 /PRNewswire/ -- Fapon Biopharma, a biotech in developing therapeutic antibodies and fusion proteins, is delighted to announce the completion of the first patient enrollment  inChina for its Phase I clinical trial of FP008 , a first-in-class immunotherapy for solid tum...

2025-08-05 16:30 1499

Sunshine Lake Pharma Co., Ltd. (06887.HK) Completes Listing, Market Capitalisation Expected to Rapidly Surpass RMB 50 Billion

GUANGZHOU, China, Aug. 5, 2025 /PRNewswire/ -- Sunshine Lake Pharma Co., Ltd. (06887.HK) announced that the company will officially list on the Hong Kong Stock Exchange onAugust 7th. Through this integration, the company has effectively combined its expertise in drug R&D with the mature nationwid...

2025-08-05 15:34 1690

Chugai Pharma Taiwan Honored at the AREA 2025 for its Social Empowerment and Green Innovation

BANGKOK, Aug. 4, 2025 /PRNewswire/ -- Chugai Pharma Taiwan (CPT), a subsidiary of Chugai Pharmaceutical Co., Ltd. inJapan, has been recognized in both the Social Empowerment and Green Leadership categories at the Asia Responsible Enterprise Awards (AREA) 2025. These recognitions highlight the com...

2025-08-05 13:02 2428

WuXi XDC Achieves GMP Release of Newly Launched DP3 Facility at Wuxi Site, Scaling Further Drug Product Manufacturing Capacity

WUXI, China, Aug. 4, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced that the Drug Product 3 ("DP3") facility at the Wuxi site has c...

2025-08-05 10:13 1556

Smart Jelly for Smart Aging: Chula's High-Protein Pudding Takes Global Stage

BANGKOK, Aug. 5, 2025 /PRNewswire/ -- Chulalongkorn University 's "High-Protein Jelly Pudding with Modified Texture for the Elderly with Swallowing Difficulties," developed by Asst. Prof. Dr. Varanya Techasukthavorn and a team from the Faculty of Allied Health Scienc...

2025-08-05 10:00 2027

Innovent Receives U.S. FDA Approval for IND Application of Oral GLP-1R Agonist IBI3032

SAN FRANCISCO and SUZHOU, China, Aug. 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...

2025-08-05 08:00 1597

LA ROCHE-POSAY AND GLOBAL SKIN HEALTH EXPERTS UNITE TO WARN ABOUT LONG TERM CONSEQUENCES OF DANGEROUS 'BURN LINES' SOCIAL MEDIA TREND

PARIS, Aug. 5, 2025 /PRNewswire/ -- A viral TikTok challenge known as "Burn Lines" or "Sunburn Tattoos" is gaining alarming traction among teenagers and young adults worldwide. The trend, which involves placing tape or stencils on the skin to intentionally burn patterned tan lines, has sparked wi...

2025-08-05 05:15 1603

Pulsecare Medical Announces NMPA Approval of NxPFA™, the World's First Nanosecond PFA System, Ushering in the PFA 3.0 Era

SHENZHEN, China, Aug. 4, 2025 /PRNewswire/ -- Pulsecare Medical, a pioneer in cardiovascular intervention technologies, announced that its innovativeNxPFA™ nanosecond pulsed field ablation (ns-PFA) systemhas received marketing approval fromChina's National Medical Products Administration (NMPA). ...

2025-08-04 21:30 1835

Vatech Introduces 'Clever One' - A Game-Changing Dental Viewer Solution for the U.S. Market.

FDA-cleared AI dental platform integrates diagnostic support, treatment planning, and patient consultation into one seamless workflow TEANECK, N.J., Aug. 4, 2025 /PRNewswire/ -- Vatech, a global leader in dental imaging innovation, has officially launched 'Vatech® Clever One', its next-generatio...

2025-08-04 21:00 1812

Minaris Advanced Therapies Opens New State-of-the-Art GMP Facility to Support Global Cell and Gene Therapy Growth

MUNICH, Aug. 4, 2025 /PRNewswire/ -- Minaris Advanced Therapies, a leading global contract development and manufacturing organization and testing provider, has announced the opening of its new GMP manufacturing facility in Munich, Germany.  The facility, located in Taufkirchen, strengthens Minaris...

2025-08-04 21:00 2006

Breaking Through Core CT Technology Barriers!

World-Class Innovations to Debut at 2025 Medtec in September SHANGHAI, Aug. 4, 2025 /PRNewswire/ -- A quiet revolution is underway in the field of high-end medical equipment, led byChina's growing innovation power. Core CT technologies, once dominated byinternational giants, are now being steadi...

2025-08-04 16:40 1540
1 ... 59606162636465 ... 646

Week's Top Stories